Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 31, 2019

SELL
$217.4 - $246.08 $3.06 Million - $3.46 Million
-14,078 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$206.05 - $248.17 $269,925 - $325,102
-1,310 Reduced 8.51%
14,078 $3.52 Million
Q4 2018

Jan 30, 2019

SELL
$204.73 - $257.93 $542,534 - $683,514
-2,650 Reduced 14.69%
15,388 $3.47 Million
Q3 2018

Oct 23, 2018

BUY
$233.07 - $256.0 $275,721 - $302,848
1,183 Added 7.02%
18,038 $4.71 Million
Q2 2018

Aug 09, 2018

BUY
$208.1 - $233.85 $714,823 - $803,274
3,435 Added 25.6%
16,855 $4.04 Million
Q1 2018

May 08, 2018

SELL
$205.46 - $240.27 $16,436 - $19,221
-80 Reduced 0.59%
13,420 $2.91 Million
Q4 2017

Feb 08, 2018

SELL
$189.0 - $222.64 $94,500 - $111,320
-500 Reduced 3.57%
13,500 $2.89 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $2.62 Million - $2.78 Million
14,000
14,000 $2.74 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Geneva Partners, LLC Portfolio

Follow Geneva Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Partners, LLC with notifications on news.